This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1961 Apr:13:346-53.

doi: 10.1016/0021-9681(61)90060-1.

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

PMID: 13704181
DOI: 10.1016/0021-9681(61)90060-1

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

E A GEHAN. J Chronic Dis. 1961 Apr.

. 1961 Apr:13:346-53.

doi: 10.1016/0021-9681(61)90060-1.

Author

PMID: 13704181
DOI: 10.1016/0021-9681(61)90060-1

No abstract available

PubMed Disclaimer

Similar articles

[EXPERIMENTAL STUDIES ON CARCINOMA AND ITS ARRESTED STATE. 9. PHARMACOLOGY OF URACIL MUSTARD, A CHEMOTHERAPEUTIC ANTINEOPLASTIC AGENT].
CHANG M. CHANG M. Nihon Yakurigaku Zasshi. 1964 Sep 20;60:413-34. Nihon Yakurigaku Zasshi. 1964. PMID: 14271233 Japanese. No abstract available.
[HEMATOLOGICAL RESPONSE TO VARIOUS CHEMOTHERAPEUTIC AGENTS].
GAVINHA CJ, REBELLO E. GAVINHA CJ, et al. Arq Oncol. 1963;5:227-8. Arq Oncol. 1963. PMID: 14118634 Portuguese. No abstract available.
The pharmacology of some chemotherapeutic agents.
SMITH RG. SMITH RG. Bull Tulane Univ Med Fac. 1947-1948;7(2):31-7. Bull Tulane Univ Med Fac. 1947. PMID: 18911071 No abstract available.
Pharmacology and toxicology of chemotherapeutic agents.
Rodrigues RL. Rodrigues RL. Emerg Med Clin North Am. 1993 May;11(2):431-43. Emerg Med Clin North Am. 1993. PMID: 8491115 Review.
Pharmacology and pharmacogenetics of chemotherapeutic agents.
Dawood S, Leyland-Jones B. Dawood S, et al. Cancer Invest. 2009 Jun;27(5):482-8. doi: 10.1080/07357900802574660. Cancer Invest. 2009. PMID: 19479485 Review.

See all similar articles

Cited by

A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rules.
Wang J, Ma J, Cai C, Daver N, Ning J. Wang J, et al. Stat Med. 2021 Sep 20;40(21):4629-4639. doi: 10.1002/sim.9084. Epub 2021 Jun 7. Stat Med. 2021. PMID: 34101217 Free PMC article.
Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision Oncology.
Polley MC, Cheung YK. Polley MC, et al. JCO Precis Oncol. 2019 Oct 24;3:PO.19.00057. doi: 10.1200/PO.19.00057. eCollection 2019. JCO Precis Oncol. 2019. PMID: 32923846 Free PMC article. Review.
Advances in Statistical Approaches Oncology Drug Development.
Ivanova A, Rosner GL, Marchenko O, Parke T, Perevozskaya I, Wang Y. Ivanova A, et al. Ther Innov Regul Sci. 2014 Jan;48(1):81-89. doi: 10.1177/2168479013501309. Ther Innov Regul Sci. 2014. PMID: 25949927 Free PMC article.
Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia.
Archimbaud E, Troncy J, Sebban C, Guyotat D, Devaux Y, French M, Moriceau M, Viala JJ, Fiere D. Archimbaud E, et al. Cancer Chemother Pharmacol. 1989;25(3):223-5. doi: 10.1007/BF00689589. Cancer Chemother Pharmacol. 1989. PMID: 2532073
Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.
Macheledt JE, Buzdar AU, Hortobagyi GN, Frye DK, Gutterman JU, Holmes FA. Macheledt JE, et al. Breast Cancer Res Treat. 1991 Aug;18(3):165-70. doi: 10.1007/BF01990032. Breast Cancer Res Treat. 1991. PMID: 1756259 Clinical Trial.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database